Mátyus, Péter <br/><br/>
Novel antiarrhythmic compounds with combined class IB and class III mode of action.  [electronic resource] 

 -  Current medicinal chemistry  Jan 2004 
 - 61-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0929-8673 
<br/><br/><label>Standard No.: </label>10.2174/0929867043456232  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Animals<br/>Anti-Arrhythmia Agents--chemical synthesis<br/>Coronary Disease--drug therapy<br/>Delayed Rectifier Potassium Channels<br/>Drug Design<br/>Heart Conduction System--drug effects<br/>Heart Ventricles--drug effects<br/>Mexiletine--pharmacology<br/>Papillary Muscles--drug effects<br/>Phenethylamines--pharmacology<br/>Potassium Channels--drug effects<br/>Potassium Channels, Voltage-Gated<br/>Sotalol--pharmacology<br/>Sulfonamides--pharmacology<br/>Ventricular Function